This is evidenced by the fact that industry […] Moderna (MRNA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the ...

This is evidenced by the fact that industry […] Moderna (MRNA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key ...

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...

Several Kentucky bills filed this legislative session have one thing in common: a shared skepticism of guidance from top U.S.

While billions pour into pharmaceutical biotech, officials and experts warn there’s much less private investment in products more relevant to the military, like body armor materials, anti-corrosion ...

As a result, domestically produced products, with active pharmaceutical ingredients manufactured ... formulation processes and STARR® sa-mRNA drug substance manufacturing." About sa-mRNA mRNA ...

Market report delivers crucial insights into the market's growth trajectory and the primary revenue drivers anticipated ...

Shares of Lonza Group AG (SIX: LONN) fell more than 3% on Wednesday after the company reported full-year 2024 earnings that showed flat revenue growth and a dip i ...

Candy Massaroni and two Republican cosponsors are pushing a bill that would block health care facilities or providers from transfusing blood unless it tests negative for COVID-19 antibodies and ...

Swiss Biotechnology firm Lonza, which purchased the Genentech facility in Vacaville last year, reported an income of 6.6 billion in Swiss francs (CHF) for the year 2024, which converts to about ...

Pharmaceutical Lipids Market to Reach USD 9,036.5 Million by 2035, Rising demand for lipid-based drug delivery fuels market ...

Synthetic biologists from Yale were able to re-write the genetic code of an organism—a novel genomically recoded organism ...